3.9 based on 7 reviewsView this provider's reviews
Patient satisfaction ratings and reviews are based on personal opinions. Before you choose any doctor you should take into account their background, training, specialized experience AND their patient satisfaction to ensure they are the right fit for you.
Accepting new patients
Dr. Maria De Sancho, MD is a hematology doctor who practices in New York, NY. She is 58 years old and has been practicing for 34 years. Read her story
We're trying something new with Top Care Areas.Was it helpful for you?YesNo
Dr. De Sancho's bio
This content was provided by Dr. De Sancho "Dr. DeSancho received her MD from the Autonomous University in Spain in 1983. Following a Residency in Family Practice at La Paz Hospital in Spain and a Residency in Internal Medicine at Metropolitan Hospital Center in New York, she completed fellowships in Hematology at Montefiore Medical Center from 1991-1992 and the Mount Sinai Medical Center from 1992-1993. Following this, she completed three additional fellowships at Mount Sinai in Transfusion Medicine, Medical Oncology, and Bone Marrow Transplantation. She obtained a faculty position at Columbia University as Assistant Professor of Clinical Medicine from 1997-2000, and in 2000 was appointed as Assistant Professor of Medicine and Assistant Attending Physician at Mount Sinai. Dr. DeSancho joined Weill Cornell Medical College in 2006 and is an Associate Professor of Clinical Medicine at the college and Associate Attending Physician at the New York-Presbyterian Hospital. She serves as Service Chief of the Division's Benign Hematology Service, has developed a successful clinical research program in Benign Hematology, and conducts clinical trails in Benign Hematology. As a researcher, Dr. DeSancho's interest is in thrombosis and hemostasis, specifically thrombophilic disorders and women's health issues. She has participated in a number of important clinical studies. She has been Principal Investigator on many studies, including a Phase II multi center trail of a low molecular weight heparin for patients requiring bridging of anticoagulant therapy, a trial of cancer-associated thrombosis, and studies on thromboembolism in women's health. She is currently the principal investigator in a clinical trial for secondary prevention of venous thrombosis and in a clinical trial using plasma derived antithrombin in patients with hereditary antithrombin deficiency."
This content was provided by Dr. De Sancho "I have been Service Chief of the BenignHematology Service in the Division of Hematology and Medical Oncology since 2006. As a clinician, my main interest is in the care of patients with thrombotic and bleeding disorders. As a researcher who conducts clinical trials in Benign Hematology, my interest is in thrombosis and hemostasis, specifically thrombophilic disorders and women's health issues. It is my hope that through dedication to the care of each individual patient, and dedication to research that will ultimately improve that care, we will meet our overall mission of helping our patients to have a better quality of life."
Accredited by: American Board of Internal Medicine*
Acute Lymphocytic Leukemia
Acute Myeloid Leukemia
Antiphospholipid Syndrome (APS)
Blood Disorders in Pregnancy
Central Nervous System Lymphoma
Coagulation Defects in Pregnancy and Postpartum
Coagulation Disorders (incl. Hemophilia)
Deep Vein Thrombosis (DVT)
Graft vs Host Disease
Immune Thrombocytopenic Purpura (ITP)
Mantle Cell Lymphoma
Polycythemia Rubra Vera
Primary Central Nervous System Lymphoma
Primary Hypercoagulable State (incl. Factor V Leiden Disease)